Amod Sarnaik

14PUBLICATIONS
115CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyEngineering electromagneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Andrew S Brohl, Vernon K Sondak, Evan J Wuthrick

|Jul 22, 2025
Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors.

Harriet Kluger, Götz Ulrich Grigoleit, Sajeve Thomas

|Jun 02, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.

Theresa Medina, Jason A Chesney, Harriet M Kluger

|Apr 08, 2025
CD40L stimulates tumor-infiltrating B-cells and improves ex vivo TIL expansion.

Renata Ariza Marques Rossetti, Leticia Tordesillas, Matthew S Beatty

|Oct 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.

Ahmad A Tarhini, Zeynep Eroglu, Islam Eljilany

|Jul 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.

Zachary Z Reinstein, Yue Zhang, Oscar E Ospina

Pageof 3

Frequent Collaborators

7 joint publications

Nikhil I Khushalani

4 joint publications

Vernon K Sondak

3 joint publications

Andrew S Brohl

3 joint publications

Zeynep Eroglu